Liver Meeting 2025. The trial achieved both its primary endpoints, with semaglutide 2.4 mg demonstrating statistically significant and superior improvements in liver fibrosis with no. Review the underlying mechanisms of hepatic fibrosis reversibility and restoration of liver function, and how this can be achieved in patients.

Can’t see the event you’re looking for? We are excited to share the upcoming dates for the easl congress with the liver community, taking place at the end of spring each year.